Intradose-FU: Started Phase II trials

By WIR Staff | Jan 17, 1994 | 8:00 AM GMT

Matrix Pharmaceutical Inc. (MATX), Menlo

Read the full 50 word article

How to gain access

Continue reading with a
two-week free trial.